|
|
Article: Israeli Government Chief Scientist Office Awards $870,000 Grant to BrainStorm Cell Therapeutics for the Second Consecutive Year.
- Article from:
- Business Wire
- Article date:
- June 16, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK & PETACH TIKVAH, Israel -- BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has been awarded a grant from Israel's prestigious Chief Scientist Office (CSO). The company will receive approximately $870,000 over the remainder of the current fiscal year to fund the continuing development of treatments for ALS and Parkinson's disease.
This is the second consecutive year that BrainStorm will be receiving this grant from the CSO. In 2007, the company was awarded a grant totaling $340,000. Based on the previous studies conducted by the company, the new ...